U.S. Influenza Diagnostics Market Size, Share & Trends Report

U.S. Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture, Others), By End Use (Hospital, Laboratories, POCT) And Segment Forecasts, 2019 - 2026

  • Published Date: Oct, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-3-68038-788-9
  • Format: Electronic (PDF)
  • Historical Data: 2015 - 2017
  • Number of Pages: 80

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Research Methodology
                      1.1.1 Information Procurement
                 1.2 Information Or Data Analysis
                 1.3 Market Formulation & Validation
                 1.4 Region-Wise Market Calculation
                      1.4.1 Region-Wise Market: Base Estimates
                      1.4.2 U.S. Market: Cagr Calculation
                 1.5 Region-Based Segment Share Calculation
                 1.6 List Of Secondary Sources
                 1.7 List Of Primary Sources
                      1.7.1 Primary Interview Breakup
                          1.7.1.1 Data For Primary Interviews, By Sources
                          1.7.1.2 Data For Primary Interviews, By Region
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 U.S. Influenza Diagnostics Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                      3.1.1 Market Driver Analysis
                          3.1.1.1 Rising Geriatric Population
                          3.1.1.2 Increasing Prevalence Of Chronic Diseases
                          3.1.1.3 Government Initiatives To Counter Influenza
                          3.1.1.4 Technological Advancements
                      3.1.2 Market Restraint Analysis
                          3.1.2.1 Product Safety And High Development Costs
                      3.1.3 Key Opportunities Prioritized
                          3.1.3.1 Key Opportunities Prioritized, By Test Type
                          3.1.3.2 Key Opportunities Prioritized, By End Use
                      3.1.4 U.S. Influenza Diagnostics - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                      3.1.5 Industry Analysis - Porter's
                      3.1.6 U.S. Influenza Diagnostics Market: Company Market Position Analysis, 2018
Chapter 4 U.S. Influenza Diagnostics Market: Test Type Analysis
                 4.1 Test Type Business Analysis
                 4.2 U.S. Influenza Diagnostics Market: Test Type Movement Analysis
                      4.2.1 Ridts
                          4.2.1.1 Ridts Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                      4.2.2 Rt-Pcr
                          4.2.2.1 Rt-Pcr Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                      4.2.3 Cell Culture
                          4.2.3.1 Cell Culture Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                      4.2.4 Other Diagnostic Tests
                          4.2.4.1 Other Diagnostic Tests Market Estimates And Forecasts, 2015 - 2026 (USD Million)
Chapter 5 U.S. Influenza Diagnostics Market: End Use Analysis
                 5.1 End-Use Business Analysis
                 5.2 U.S. Influenza Diagnostics Market: End-Use Movement Analysis
                      5.2.1 Hospitals
                          5.2.1.1 Hospitals Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                      5.2.2 Poct
                          5.2.2.1 Poct Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                      5.2.3 Laboratories
                          5.2.3.1 Laboratories Market Estimates And Forecasts, 2015 - 2026 (USD Million)
Chapter 6 U.S. Influenza Diagnostics Market: Regional Estimates & Trend Analysis, By Test Type, End-Use
                 6.1 U.S.
Chapter 7 Competitive Landscape
                 7.1 Company Profiles
                      7.1.1 3M COMPANY
                          7.1.1.1 Company Overview
                          7.1.1.2 Financial Performance
                          7.1.1.3 Product Benchmarking
                      7.1.2 ALERE
                          7.1.2.1 Company Overview
                          7.1.2.2 Product Benchmarking
                          7.1.2.3 Strategic Initiatives
                      7.1.3 BECTON, DICKINSON AND COMPANY (BD)
                          7.1.3.1 Company Overview
                          7.1.3.2 Financial Performance
                          7.1.3.3 Product Benchmarking
                          7.1.3.4 Strategic Initiatives
                      7.1.4 MERIDIAN BIOSCIENCE, INC.
                          7.1.4.1 Company Overview
                          7.1.4.2 Financial Performance
                          7.1.4.3 Product Benchmarking
                      7.1.5 QUIDEL CORPORATION
                          7.1.5.1 Company Overview
                          7.1.5.2 Financial Performance
                          7.1.5.3 Product Benchmarking
                      7.1.6 ROCHE DIAGNOSTICS CORPORATION
                          7.1.6.1 Company Overview
                          7.1.6.2 Financial Performance
                          7.1.6.3 Product Benchmarking
                          7.1.6.4 Strategic Initiatives
                      7.1.7 SA SCIENTIFIC
                          7.1.7.1 Company Overview
                          7.1.7.2 Financial Performance
                          7.1.7.3 Product Benchmarking
                      7.1.8 SEKISUI DIAGNOSTICS
                          7.1.8.1 Company Overview
                          7.1.8.2 Financial Performance
                          7.1.8.3 Product Benchmarking
                          7.1.8.4 Strategic Initiatives
                      7.1.9 THERMO FISHER SCIENTIFIC, INC.
                          7.1.9.1 Company Overview
                          7.1.9.2 Financial Performance
                          7.1.9.3 Product Benchmarking
                          7.1.9.4 Strategic Initiatives


List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/product disruptors/innovators
Table 3 U.S influenza diagnostics Market, by test type, 2015 - 2026 (USD Million)
Table 4 U.S influenza diagnostics Market, by end-use, 2015 - 2026 (USD Million)
Table 5 Influenza Diagnostic Tests Performed in the U.S. 2015 - 2026 (Thousands)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Primary interviews, by sources
Fig. 9 Primary interviews, by region
Fig. 10 U.S. influenza diagnostics market summary
Fig. 11 U.S. Influenza diagnostics market trends and outlook
Fig. 12 U.S. Influenza diagnostics market segmentation
Fig. 13 U.S. influenza diagnostics market driver impact
Fig. 14 U.S. influenza diagnostics market restraint impact
Fig. 15 Key opportunities prioritized, test type
Fig. 16 Key opportunities prioritized, end-use
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 U.S. influenza diagnostics market, Heat map analysis, 2018
Fig. 20 U.S. influenza diagnostics test type outlook: Key takeaways
Fig. 21 U.S. influenza diagnostics market: Test type movement analysis
Fig. 22 U.S. influenza RIDTs market, 2015 - 2026 (USD Million)
Fig. 23 U.S. influenza RT-PCR market, 2015 - 2026 (USD Million)
Fig. 24 U.S. influenza cell culture market, 2015 - 2026 (USD Million)
Fig. 25 U.S. influenza other diagnostic tests market, 2015 - 2026 (USD Million)
Fig. 26 U.S. Influenza Diagnostics market end-use outlook: Key takeaways
Fig. 27 U.S. Influenza Diagnostics market: End-use movement analysis
Fig. 28 U.S. influenza hospitals market, 2015 - 2026 (USD Million)
Fig. 29 U.S. influenza POCT market, 2015 - 2026 (USD Million)
Fig. 30 U.S. influenza laboratories market, 2015 - 2026 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.